FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation.

Zhu R, Li L, Nguyen B, Seo J, Wu M, Seale T, Levis M, Duffield A, Hu Y, Small D
Signal Transduct Target Ther. 2021 May 24;6(1):186. doi: 10.1038/s41392-021-00578-4. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.